VC Daily: Question: In Fintech, How Much Is Too Much for Investors? - Wall Street Journal

Retrieved on: 2021-10-01 13:52:30

Tags for this article:

Healthcare reform in the United States

Health

Articles

Drug pricing

Pharmaceutical industry

Health economics

Elijah Cummings Lower Drug Costs Now Act

Publicly funded health care

Medicare

Medication costs

Health care prices in the United States

Prescription drug prices in the United States

Click the tags to see associated articles and topics

VC Daily: Question: In Fintech, How Much Is Too Much for Investors? - Wall Street Journal. View article details on HISWAI: https://www.wsj.com/articles/vc-daily-question-in-fintech-how-much-is-too-much-for-investors-11633096474

Excerpt

VC Daily: Question: In Fintech, How Much Is Too Much for Investors? ... Good day. Last week, we asked if measures aimed at lowering prescription-drug prices that ...

Article found on: www.wsj.com

View Original Article